{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-22-002842","form_type":"8-K","ticker":"ENTXW","cik":"0001638097","company_name":"Entera Bio Ltd.","filed_at":"2022-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.488048+00:00","generated_at":"2026-06-24T06:30:57.777040+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Entera Bio releases updated corporate presentation; no specific new financial data","bullets":["Updated corporate presentation made available on August 1, 2022, on company website.","Exhibit 99.1 included but text truncated; no financial metrics or guidance changes extracted.","Presentation likely covers pipeline and business overview; no material events announced.","Stock tickers: ENTX (ordinary shares) and ENTXW (warrants)."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-22-002842","json":"https://secwatch.observer/filing/0001178913-22-002842.json","markdown":"https://secwatch.observer/filing/0001178913-22-002842.md","text":"https://secwatch.observer/filing/0001178913-22-002842.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322002842/0001178913-22-002842-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638097/000117891322002842/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T06:30:57.777040+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}